Biopharmaceutical company Aptorum Group Ltd. (NASDAQ:APM) saw its pre-market stock price ... in the same period last year on the back of $4.1 million lower operating expenses, due to the ...
Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback